Wesper Raises $9.6M in Series A Funding
- Wesper, a New York-based clinical-grade FDA-cleared wireless home sleep lab company, raised $9.6M in Series A funding
- Backers included Valor Equity Partners, Breyer Capital, and Spark Capital
- The company intends to use the funds to accelerate growth and revenue as well as continue to develop diagnostic sensing technology
- The company is a doctor-supervised sleep health program that offers a clinical-grade system designed to get users the care they need
- It enables people to meet with sleep experts and board-certified physicians to review their comprehensive sleep data and get a tailor-made treatment plan, all from the comfort of their own bed
